Entrega Bio

About:

Entrega Bio offers a proprietary technology that makes injectable substances available orally.

Website: http://www.entregabio.com

Top Investors: Eli Lilly

Description:

Entrega Bio offers a proprietary technology that makes injectable substances available orally. Its technology has the potential to deliver a wide variety of biological molecules, drug substances, and nanoparticles. Entrega Bio collaborates with pharma and non-pharma industry partners to develop the platform for innovative therapeutic and diagnostic modalities. This platform enables novel applications in a variety of fields such as disease management and tracking in the burgeoning mobile health arena. Entrega Bio is based in Boston, Massachusetts, United States.

Total Funding Amount:

$5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)entregabio.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2017-12-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai